vs
Side-by-side financial comparison of Forestar Group Inc. (FOR) and Bio-Techne (TECH). Click either name above to swap in a different company.
Bio-Techne is the larger business by last-quarter revenue ($295.9M vs $273.0M, roughly 1.1× Forestar Group Inc.). Bio-Techne runs the higher net margin — 12.8% vs 5.6%, a 7.2% gap on every dollar of revenue. On growth, Forestar Group Inc. posted the faster year-over-year revenue change (9.0% vs -6.4%). Over the past eight quarters, Bio-Techne's revenue compounded faster (4.2% CAGR vs -9.6%).
Forestar Group Inc. is a residential lot development company based in Arlington, Texas. The company has operations in 51 markets in 21 states and delivered 11,518 residential lots during the twelve-month period ended December 31, 2020. The company is publicly traded on the New York Stock Exchange and in October 2017 became a majority-owned subsidiary of D.R. Horton, Inc., the largest homebuilder by volume in the United States since 2002. The company primarily acquires entitled real estate and...
Bio-Techne Corporation is an American life sciences company that develops, manufactures and sells life science reagents, instruments and services for the research, diagnostic, and bioprocessing markets.
FOR vs TECH — Head-to-Head
Income Statement — Q1 FY2026 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $273.0M | $295.9M |
| Net Profit | $15.4M | $38.0M |
| Gross Margin | 20.1% | 64.6% |
| Operating Margin | 7.6% | 18.4% |
| Net Margin | 5.6% | 12.8% |
| Revenue YoY | 9.0% | -6.4% |
| Net Profit YoY | -6.7% | 68.3% |
| EPS (diluted) | $0.30 | $0.24 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $273.0M | $295.9M | ||
| Q3 25 | $670.5M | — | ||
| Q2 25 | $390.5M | $317.0M | ||
| Q1 25 | $351.0M | $316.2M | ||
| Q4 24 | $250.4M | $297.0M | ||
| Q3 24 | $551.3M | $289.5M | ||
| Q2 24 | $318.4M | $306.1M | ||
| Q1 24 | $333.8M | $303.4M |
| Q4 25 | $15.4M | $38.0M | ||
| Q3 25 | $86.9M | — | ||
| Q2 25 | $32.9M | $-17.7M | ||
| Q1 25 | $31.6M | $22.6M | ||
| Q4 24 | $16.5M | $34.9M | ||
| Q3 24 | $81.5M | $33.6M | ||
| Q2 24 | $38.7M | $40.6M | ||
| Q1 24 | $45.0M | $49.1M |
| Q4 25 | 20.1% | 64.6% | ||
| Q3 25 | 22.3% | — | ||
| Q2 25 | 20.4% | 62.7% | ||
| Q1 25 | 22.6% | 67.9% | ||
| Q4 24 | 22.0% | 65.3% | ||
| Q3 24 | 23.9% | 63.2% | ||
| Q2 24 | 22.5% | 66.4% | ||
| Q1 24 | 24.9% | 67.4% |
| Q4 25 | 7.6% | 18.4% | ||
| Q3 25 | 16.9% | — | ||
| Q2 25 | 11.2% | -7.5% | ||
| Q1 25 | 11.6% | 12.2% | ||
| Q4 24 | 8.7% | 16.0% | ||
| Q3 24 | 19.7% | 13.8% | ||
| Q2 24 | 16.2% | 15.0% | ||
| Q1 24 | 17.6% | 22.1% |
| Q4 25 | 5.6% | 12.8% | ||
| Q3 25 | 13.0% | — | ||
| Q2 25 | 8.4% | -5.6% | ||
| Q1 25 | 9.0% | 7.1% | ||
| Q4 24 | 6.6% | 11.7% | ||
| Q3 24 | 14.8% | 11.6% | ||
| Q2 24 | 12.2% | 13.3% | ||
| Q1 24 | 13.5% | 16.2% |
| Q4 25 | $0.30 | $0.24 | ||
| Q3 25 | $1.70 | — | ||
| Q2 25 | $0.65 | $-0.11 | ||
| Q1 25 | $0.62 | $0.14 | ||
| Q4 24 | $0.32 | $0.22 | ||
| Q3 24 | $1.59 | $0.21 | ||
| Q2 24 | $0.76 | $0.26 | ||
| Q1 24 | $0.89 | $0.31 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $211.7M | $172.9M |
| Total DebtLower is stronger | $793.2M | $260.0M |
| Stockholders' EquityBook value | $1.8B | $2.0B |
| Total Assets | $3.2B | $2.5B |
| Debt / EquityLower = less leverage | 0.44× | 0.13× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $211.7M | $172.9M | ||
| Q3 25 | $379.2M | — | ||
| Q2 25 | $189.2M | $162.2M | ||
| Q1 25 | $174.3M | $140.7M | ||
| Q4 24 | $132.0M | $177.5M | ||
| Q3 24 | $481.2M | $187.5M | ||
| Q2 24 | $359.2M | $152.9M | ||
| Q1 24 | $416.2M | $145.3M |
| Q4 25 | $793.2M | $260.0M | ||
| Q3 25 | $802.7M | — | ||
| Q2 25 | $872.8M | $346.0M | ||
| Q1 25 | $872.5M | $330.0M | ||
| Q4 24 | $806.8M | $300.0M | ||
| Q3 24 | $706.4M | $300.0M | ||
| Q2 24 | $706.1M | $319.0M | ||
| Q1 24 | $705.7M | $389.0M |
| Q4 25 | $1.8B | $2.0B | ||
| Q3 25 | $1.8B | — | ||
| Q2 25 | $1.7B | $1.9B | ||
| Q1 25 | $1.6B | $2.0B | ||
| Q4 24 | $1.6B | $2.1B | ||
| Q3 24 | $1.6B | $2.1B | ||
| Q2 24 | $1.5B | $2.1B | ||
| Q1 24 | $1.5B | $2.0B |
| Q4 25 | $3.2B | $2.5B | ||
| Q3 25 | $3.1B | — | ||
| Q2 25 | $3.1B | $2.6B | ||
| Q1 25 | $3.0B | $2.6B | ||
| Q4 24 | $3.0B | $2.7B | ||
| Q3 24 | $2.8B | $2.7B | ||
| Q2 24 | $2.7B | $2.7B | ||
| Q1 24 | $2.6B | $2.7B |
| Q4 25 | 0.44× | 0.13× | ||
| Q3 25 | 0.45× | — | ||
| Q2 25 | 0.52× | 0.18× | ||
| Q1 25 | 0.53× | 0.16× | ||
| Q4 24 | 0.50× | 0.14× | ||
| Q3 24 | 0.44× | 0.14× | ||
| Q2 24 | 0.47× | 0.15× | ||
| Q1 24 | 0.48× | 0.19× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-157.0M | — |
| Free Cash FlowOCF − Capex | $-157.1M | — |
| FCF MarginFCF / Revenue | -57.5% | — |
| Capex IntensityCapex / Revenue | 0.0% | — |
| Cash ConversionOCF / Net Profit | -10.19× | — |
| TTM Free Cash FlowTrailing 4 quarters | $93.0M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-157.0M | — | ||
| Q3 25 | $256.3M | — | ||
| Q2 25 | $15.8M | $98.2M | ||
| Q1 25 | $-19.8M | $41.1M | ||
| Q4 24 | $-450.0M | $84.3M | ||
| Q3 24 | $119.2M | $63.9M | ||
| Q2 24 | $-61.7M | $75.5M | ||
| Q1 24 | $-59.2M | $81.0M |
| Q4 25 | $-157.1M | — | ||
| Q3 25 | $255.6M | — | ||
| Q2 25 | $15.0M | $93.3M | ||
| Q1 25 | $-20.5M | $31.0M | ||
| Q4 24 | — | $77.5M | ||
| Q3 24 | $118.4M | $54.7M | ||
| Q2 24 | $-62.3M | $57.5M | ||
| Q1 24 | $-59.8M | $64.5M |
| Q4 25 | -57.5% | — | ||
| Q3 25 | 38.1% | — | ||
| Q2 25 | 3.8% | 29.4% | ||
| Q1 25 | -5.8% | 9.8% | ||
| Q4 24 | — | 26.1% | ||
| Q3 24 | 21.5% | 18.9% | ||
| Q2 24 | -19.6% | 18.8% | ||
| Q1 24 | -17.9% | 21.3% |
| Q4 25 | 0.0% | — | ||
| Q3 25 | 0.1% | — | ||
| Q2 25 | 0.2% | 1.5% | ||
| Q1 25 | 0.2% | 3.2% | ||
| Q4 24 | 0.0% | 2.3% | ||
| Q3 24 | 0.1% | 3.2% | ||
| Q2 24 | 0.2% | 5.9% | ||
| Q1 24 | 0.2% | 5.4% |
| Q4 25 | -10.19× | — | ||
| Q3 25 | 2.95× | — | ||
| Q2 25 | 0.48× | — | ||
| Q1 25 | -0.63× | 1.82× | ||
| Q4 24 | -27.27× | 2.42× | ||
| Q3 24 | 1.46× | 1.90× | ||
| Q2 24 | -1.59× | 1.86× | ||
| Q1 24 | -1.32× | 1.65× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FOR
| D.R.Horton Inc. | $183.8M | 67% |
| Other | $89.2M | 33% |
TECH
| Diagnostics And Spatial Biology | $81.2M | 27% |
| EMEA Excluding UK | $75.4M | 25% |
| Other | $42.4M | 14% |
| Instruments | $29.6M | 10% |
| APAC Excluding Greater China | $22.7M | 8% |
| Services | $22.3M | 8% |
| GB | $13.7M | 5% |
| Royalty | $8.5M | 3% |
